COVID GEAS: COVID-19 National Survey in Patients With Systemic Autoimmune Diseases
ObjectivesCOVID-19 outcomes in population with systemic autoimmune diseases (SAD) remain poorly understood. The aim was to examine demographic and clinical factors associated with COVID-19 infection in people with rheumatic disease.MethodsTwo phases cross-sectional survey of individuals with rheumat...
Main Authors: | Borja Del Carmelo Gracia, Luis Sáez, Lucio Pallarés, Jose Velilla, Adela Marín, Luis Martinez-Lostao, Carmen Pilar Simeón, Patricia Fanlo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-01-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2021.808608/full |
Similar Items
-
Unveiling Ocular Manifestations in Systemic Lupus Erythematosus
by: Mutali Musa, et al.
Published: (2024-02-01) -
The Pathogenesis, Molecular Mechanisms, and Therapeutic Potential of the Interferon Pathway in Systemic Lupus Erythematosus and Other Autoimmune Diseases
by: Madhu Ramaswamy, et al.
Published: (2021-10-01) -
Development of Systemic Autoimmune Diseases in Healthy Subjects Persistently Positive for Antiphospholipid Antibodies: Long-Term Follow-Up Study
by: Fulvia Ceccarelli, et al.
Published: (2022-08-01) -
Effect of belimumab in patients with systemic lupus erythematosus treated with low dose or no corticosteroids
by: Yeo-Jin Lee, et al.
Published: (2024-03-01) -
The great imitator
by: Cristina Gozzi, et al.
Published: (2014-02-01)